Instrument Inactif

Communiqués Greenlight Biosciences Holdings Pbc

Actions

GRNA

US39536G1058

Communiqués

30/05/23	GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction	AQ
11/05/23	GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress	AQ
12/04/23	GreenLight Biosciences Releases Inaugural Sustainability Report	AQ
30/03/23	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
28/03/23	GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
28/03/23	GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results	AQ
09/03/23	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
07/03/23	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/02/23	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/02/23	GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate	GL
09/01/23	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
09/01/23	GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines	GL
09/11/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
07/11/22	GreenLight Biosciences to Participate in Upcoming Investor Conferences in November	GL
12/10/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
05/10/22	GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA	AQ
26/09/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
16/08/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	AQ
15/08/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
12/08/22	GreenLight Biosciences announces $109 million financing	GL
01/08/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
29/07/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
01/06/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)	AQ
16/05/22	GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
05/04/22	Environmental Impact Acquisition : International crop network validates Ledprona as a new Mode of Action group	PU